The estimated Net Worth of Robert D Mitchell is at least $1.68 Million dollars as of 19 May 2017. Robert Mitchell owns over 2,200 units of Endologix stock worth over $69,454 and over the last 20 years Robert sold ELGX stock worth over $1,612,453.
Robert has made over 8 trades of the Endologix stock since 2011, according to the Form 4 filled with the SEC. Most recently Robert bought 2,200 units of ELGX stock worth $9,504 on 19 May 2017.
The largest trade Robert's ever made was selling 45,000 units of Endologix stock on 7 April 2015 worth over $779,850. On average, Robert trades about 3,830 units every 69 days since 2004. As of 19 May 2017 Robert still owns at least 315,699 units of Endologix stock.
You can see the complete history of Robert Mitchell stock trades at the bottom of the page.
Robert's mailing address filed with the SEC is 2, Musick, Irvine Spectrum, Irvine, Orange, California, 92618, United States of America.
Over the last 21 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott, and Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: